BioHarvest Expands Sweetener Collaboration with Tate & Lyle to Multiple Molecules
BHST•BioHarvest Sciences expands collaboration with Tate & Lyle to develop multiple plant-based sweetener molecules using its Botanical Synthesis™ platform, reflecting strong technical progress since their 2024 agreement. This partnership could accelerate BioHarvest’s revenue growth by leveraging Tate & Lyle’s global ingredient network and rising sugar reduction demand.
1. Expanded Collaboration
BioHarvest Sciences broadened its 2024 sweetener development program with Tate & Lyle to include multiple plant-based molecules, building on strong technical progress to date and expanded formulation flexibility for diverse food and beverage applications.
2. Platform Technology
BioHarvest’s Botanical Synthesis™ platform uses non-GMO plant cell cultures in industrial bioreactors to produce high-value sweetener compounds with enhanced potency, purity, consistency and scalable output compared to traditional agricultural extraction.
3. Strategic Implications
The collaboration taps into growing global sugar-reduction trends and gives BioHarvest access to Tate & Lyle’s global ingredient network, positioning the company to accelerate commercial applications and revenue growth in next-generation sweetener markets.
